Specimen Requirements

Title

LUPUS ANTICOAGULANT (dRVVT AND PTT SCREEN)

Specimen Requirement

Patient should not be on warfarin (coumadin) therapy for 2 weeks or heparin therapy for 2 days prior to the test. If the patient is currently on warfarin or heparin, this should be noted, as warfarin or heparin therapy can affect certain coagulation factors or assays, preclude their performance or cause spurious results.

Draw blood in a light blue sodium citrate tube (see coagulation collection instructions). Spin to separate and freeze 2.0 mL plasma in a screw-capped plastic vial. Label transport tube “plasma/lt blue” and contact lab for dry ice.

Methodology

Stability

Room Temp 8 hours; Frozen 1 month

Reference Range

By Report*

Turnaround

1-3 days Performed Mon-Fri

Clinical Use

The presence of Lupus Anticoagulant can cause hypercoagulable states, as well as fetal loss. Due to its heterogeneous nature, no single assay can absolutely identify the presence of LA in every test plasma.

Test Code

LUPAW